High Proteolytic Resistance of Spider-Derived Inhibitor Cystine Knots

• Published in: International Journal of Peptides Vol. 2015; pp. 537508 - 8
• Main Authors: Kikuchi, Kyoko, Sugiura, Mika, Kimura, Tadashi
• Format: Journal Article
• Language: English
• Published: United States Hindawi Limiteds 2015; Hindawi Publishing Corporation; Hindawi Limited
• Subjects: Bioavailability; Cystine; Enzymes; Evolution; Health aspects; Methods; Peptides; Plasma; Proteolysis; R&D; Research & development; Stomach
• ISSN: 1687-9767; 1687-9775
• DOI: 10.1155/2015/537508

Proteolytic stability in gastrointestinal tract and blood plasma is the major obstacle for oral peptide drug development. Inhibitor cystine knots (ICKs) are linear cystine knot peptides which have multifunctional properties and could become promising drug scaffolds. ProTx-I, ProTx-II, GTx1-15, and GsMTx-4 were spider-derived ICKs and incubated with pepsin, trypsin, chymotrypsin, and elastase in physiological conditions to find that all tested peptides were resistant to pepsin, and ProTx-II, GsMTx-4, and GTx1-15 showed resistance to all tested proteases. Also, no ProTx-II degradation was observed in rat blood plasma for 24 hours in vitro and ProTx-II concentration in circulation decreased to half in 40 min, indicating absolute stability in plasma and fast clearance from the system. So far, linear peptides are generally thought to be unsuitable in vivo, but all tested ICKs were not degraded by pepsin and stomach could be selected for the alternative site of drug absorption for fast onset of the drug action. Since spider ICKs are selective inhibitors of various ion channels which are related to the pathology of many diseases, engineered ICKs will make a novel class of peptide medicines which can treat variety of bothering symptoms.